TLSI

TriSalus Life Sciences Inc.

• PUBT·3m ago

  TriSalus Life Sciences to host virtual KOL webinar on liver cancer drug delivery evidence

• PUBT·4m ago

  TriSalus says real-world study shows 48% boost in liver tumor drug delivery using PEDD technology

• PR Newswire·1d ago

  TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm

• TipRanks·05/29 14:00

  Wall Street Analysts Are Bullish on Top Healthcare Picks

• TipRanks·05/19 13:30

  Analysts’ Top Healthcare Picks: Compugen (CGEN), TriSalus Life Sciences (TLSI)

• TipRanks·05/19 02:16

  TriSalus Leaders Quietly Make a Bold Bet on the Company’s Future

• PUBT·05/18 20:43

  TriSalus director Mats Wahlstrom buys 60,000 shares worth $151,800

• PUBT·05/18 20:43

  TriSalus director Michael P Stansky acquires common shares worth $1.53 million

• PUBT·05/18 20:43

  TriSalus CFO David Patience acquires 7,100 shares for $17,253

• PUBT·05/18 20:43

  TriSalus director Gary B. Gordon acquires 10,000 common shares for $24,600

• TipRanks·05/14 21:23

  TriSalus Stockholders Back Directors, Auditor and Pay Policies

• PUBT·05/14 20:04

  TriSalus Life Sciences holds annual stockholder meeting

• TipRanks·05/14 13:16

  Maxim Group Reaffirms Their Buy Rating on TriSalus Life Sciences (TLSI)

• TipRanks·05/14 00:42

  TriSalus Life Sciences Bets Big Amid FDA Delay

• Dow Jones·05/13 20:27

  TriSalus Life Sciences Price Target Cut to $8.00/Share From $10.00 by Lake Street